In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in unborn babies that result in low amniotic fluid.[3][4] They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy.[3][4]
^ abMichele, T. M. (2014, January 16). Center for Drug Evaluation and Research: Summary Review. Retrieved April 21, 2016, from http://www.accessdata.fda.gov